Epizyme, Inc.
Method of treating leukemia
Last updated:
Abstract:
The present invention relates to methods of treating disorders in which DOT1L-mediated protein methylation plays a part, such as cancer, by administering DOT1L inhibitor compounds and pharmaceutical compositions to subjects in need thereof.
Status:
Grant
Type:
Utility
Filling date:
10 Dec 2018
Issue date:
5 Jan 2021